Vasoactive Intestinal Peptide (VIP) is a 28-amino-acid neuropeptide that regulates numerous physiological processes through interactions with specialized cell-surface receptors known as VPAC1 and VPAC2.
These receptors belong to the class B family of G protein-coupled receptors (GPCRs) and are responsible for transmitting VIP-mediated signals into cells.
The primary VIP peptide mechanism of action involves receptor activation, stimulation of adenylyl cyclase, increased intracellular cyclic adenosine monophosphate (cAMP), and activation of downstream signaling proteins.
These molecular processes contribute to VIP’s involvement in gastrointestinal regulation, neuronal communication, immune signaling, and vascular physiology.
Understanding how VPAC1 and VPAC2 receptors work is essential for interpreting the biological effects observed in laboratory studies of VIP.
For an introduction to its molecular structure and physiological functions, see our What Is VIP Peptide? Structure, Function, and Research Overview.
What Are VPAC1 and VPAC2 Receptors?
VPAC1 and VPAC2 are two major receptors activated by vasoactive intestinal peptide.
Both belong to the class B1 GPCR family, which contains receptors for several peptide hormones, including glucagon, secretin, and pituitary adenylate cyclase-activating polypeptide (PACAP).
The receptors are encoded by separate genes:
- VPAC1: Encoded by the VIPR1 gene.
- VPAC2: Encoded by the VIPR2 gene.
Both recognize VIP and PACAP with relatively high affinity, but they differ in their tissue distribution, regulatory mechanisms, and involvement in physiological functions.
A third related receptor, PAC1, primarily recognizes PACAP and generally displays substantially lower affinity for VIP.
These differences are important because they help explain why closely related peptides can produce distinct biological responses.
Scientific reference: Harmar et al. (2012), Pharmacology and Functions of VIP and PACAP Receptors.
How Does VIP Peptide Work? Step-by-Step Mechanism
The main VIP signaling pathway begins when the peptide binds to VPAC1 or VPAC2 on the surface of a responsive cell.
Step 1: VIP Binds to VPAC Receptors
VIP interacts with extracellular regions of VPAC1 and VPAC2 receptors.
Both receptors contain seven transmembrane alpha-helical domains, a defining structural characteristic of GPCRs.
Peptide binding stabilizes an active receptor conformation and allows intracellular signaling proteins to interact with the receptor.
Structural and molecular dynamics studies have investigated how particular amino acid interactions contribute to ligand recognition and receptor selectivity.
Step 2: Activation of G Proteins
After VIP binds to its receptor, the receptor undergoes a conformational change that promotes activation of associated heterotrimeric G proteins.
VPAC1 and VPAC2 primarily signal through the stimulatory G protein Gαs.
Activation involves exchanging GDP for GTP on the Gα subunit, allowing the G protein to regulate intracellular effectors.
The precise downstream signaling response depends on the receptor subtype, cell type, and associated signaling proteins.
Step 3: Stimulation of Adenylyl Cyclase
Activated Gαs stimulates the enzyme adenylyl cyclase.
Adenylyl cyclase converts adenosine triphosphate (ATP) into cyclic adenosine monophosphate (cAMP).
The resulting increase in intracellular cAMP acts as an important second messenger.
Step 4: Activation of Protein Kinase A
Elevated intracellular cAMP activates protein kinase A (PKA).
PKA phosphorylates various intracellular proteins, influencing cellular processes such as:
- Ion-channel regulation
- Gene transcription
- Hormone and neurotransmitter secretion
- Smooth muscle signaling
- Immune-cell responses
- Cellular metabolic regulation
Other cAMP-dependent proteins, including exchange proteins directly activated by cAMP (EPAC), may also participate in signaling.
Step 5: Cellular Responses
The final biological response depends on the cell expressing the activated receptor.
For example, VIP-mediated signaling may influence intestinal fluid secretion in epithelial cells, smooth muscle behavior in gastrointestinal tissues, or signaling activity within particular neuronal networks.
Primary VIP Signaling Pathway
VIP → VPAC1/VPAC2 → Gαs → Adenylyl Cyclase → cAMP → PKA/EPAC → Cellular Response
This represents the principal signaling mechanism, although additional pathways may become active in specific experimental systems.
Scientific reference: Langer (2012), Mechanisms Involved in VPAC Receptor Activation and Regulation.
VPAC1 vs VPAC2: Key Molecular Differences
Although VPAC1 and VPAC2 share important structural and functional characteristics, they are not identical receptors.
Their differences include gene expression, tissue distribution, signaling regulation, and involvement in particular physiological processes.
| Characteristic | VPAC1 | VPAC2 |
|---|---|---|
| Gene | VIPR1 | VIPR2 |
| Receptor family | Class B1 GPCR | Class B1 GPCR |
| Primary ligands | VIP and PACAP | VIP and PACAP |
| Main signaling | Gαs–cAMP–PKA | Gαs–cAMP–PKA |
| Additional signaling | Cell-dependent PLC and calcium pathways | Cell-dependent PLC and calcium pathways |
| Notable research areas | Gastrointestinal and immune signaling | Circadian, endocrine, and immune signaling |
| Receptor regulation | Internalization and desensitization | Internalization and desensitization |
Both receptor types occur in multiple tissues, and their functions overlap considerably.
The distinction is therefore not that VPAC1 controls one biological system while VPAC2 controls another. Instead, receptor expression patterns and cell-specific signaling determine their relative contributions.
Scientific reference: VPAC Receptors: Structure, Molecular Pharmacology and Interaction With Accessory Proteins.
VIP Peptide and the cAMP Signaling Pathway
One of the most extensively studied aspects of VIP receptor pharmacology is its relationship with intracellular cAMP signaling.
cAMP serves as a second messenger that translates receptor activation into changes in cellular function.
When VIP binds to VPAC1 or VPAC2, the resulting elevation in intracellular cAMP can influence several downstream pathways.
Protein Kinase A Signaling
PKA activation contributes to the regulation of enzymes, ion channels, and transcription factors.
In experimental systems, this signaling pathway has been associated with changes in secretion, gene expression, and inflammatory mediator production.
EPAC-Dependent Signaling
In addition to PKA, cAMP can activate EPAC proteins, which regulate certain small GTPases and associated intracellular pathways.
This creates additional complexity in VIP-mediated signaling because cellular responses may involve multiple cAMP-sensitive proteins rather than PKA alone.
MAPK and ERK Signaling
Depending on the cell type and experimental conditions, VIP receptor activation can also influence mitogen-activated protein kinase pathways, including extracellular signal-regulated kinases (ERK).
These pathways contribute to cellular signaling processes associated with differentiation, survival, and gene regulation.
Importantly, activation of a signaling pathway does not automatically indicate a beneficial biological or clinical effect.
Scientific reference: Signal Transduction by VIP and PACAP Receptors (2022).
Can VIP Activate Other Signaling Pathways?
Although the Gαs–cAMP pathway is the dominant mechanism, studies have demonstrated that VPAC receptor signaling can involve additional intracellular pathways.
Phospholipase C (PLC) Signaling
Under certain cellular conditions, VPAC receptors can interact with alternative G proteins that influence phospholipase C activity.
PLC signaling can lead to the production of inositol trisphosphate (IP3) and diacylglycerol (DAG).
These second messengers contribute to intracellular calcium mobilization and activation of protein kinase C (PKC).
Calcium Signaling
Calcium acts as an intracellular signaling molecule involved in secretion, muscle activity, and other cellular functions.
Research has demonstrated that VIP can alter intracellular calcium concentrations in particular experimental systems.
However, the magnitude and mechanism of these effects vary considerably between cell types.
Receptor Desensitization and Internalization
Sustained or repeated receptor activation may lead to regulatory processes that reduce cellular responsiveness.
These include receptor phosphorylation, interactions with regulatory proteins, and receptor internalization.
Such mechanisms are important when evaluating ligand exposure and receptor behavior in experimental studies.
Scientific reference: Mechanisms Involved in VPAC Receptor Activation and Regulation.
How VPAC1 and VPAC2 Signaling Influences Biological Functions
1. VIP and Immune Signaling
VPAC receptors are expressed by multiple immune-cell populations.
Experimental studies have investigated VIP-mediated effects on macrophages, dendritic cells, and T lymphocytes.
In particular experimental settings, VIP signaling can influence the production of inflammatory mediators and the activity of transcription factors associated with immune responses.
These findings have generated interest in the relationship between neuropeptide signaling and immune regulation.
However, such observations should not be interpreted as proof of clinical efficacy in inflammatory or autoimmune diseases.
Reference: Vasoactive Intestinal Peptide: A Neuropeptide With Pleiotropic Immune Functions.
2. VIP and Gastrointestinal Signaling
VIP is expressed in enteric neurons and contributes to communication within the gastrointestinal nervous system.
Through VPAC receptor activation, it participates in the regulation of:
- Intestinal fluid and electrolyte secretion
- Smooth muscle activity
- Gastrointestinal motility
- Pancreatic secretion
- Local vascular signaling
The relative contribution of VPAC1 and VPAC2 depends on the tissue and experimental model.
Reference: Recent Advances in VIP Physiology and Pathophysiology: Focus on the Gastrointestinal System.
3. VIP and Circadian Rhythm Research
One of the most interesting functions associated with VPAC2 involves circadian rhythm regulation.
VIP-producing neurons are present in the suprachiasmatic nucleus (SCN), the brain region responsible for coordinating central biological rhythms.
VIP–VPAC2 signaling contributes to synchronization between neuronal populations within this network.
Animal studies involving altered VIP or VPAC2 signaling have demonstrated changes in circadian rhythm organization.
These observations support ongoing investigations into how neuropeptide receptor signaling contributes to biological timekeeping.
Reference: Pharmacology and Functions of VIP and PACAP Receptors.
4. VIP and Vascular Signaling
VIP can influence vascular smooth muscle activity through receptor-mediated signaling.
In experimental models, receptor activation may alter intracellular signaling pathways involved in smooth muscle relaxation and vascular responses.
However, the physiological outcome depends on receptor expression, tissue conditions, and interactions with other signaling molecules.
VIP vs PACAP: Why Receptor Selectivity Matters
VIP is closely related to pituitary adenylate cyclase-activating polypeptide (PACAP).
Both are members of the secretin/glucagon peptide family and interact with VPAC1 and VPAC2.
However, PACAP also binds effectively to the PAC1 receptor, whereas VIP generally has much lower affinity for PAC1.
This difference is important when comparing their pharmacological effects.
Researchers have used receptor-binding experiments, structural analysis, and computational molecular dynamics to investigate the mechanisms responsible for these differences.
Studies suggest that distinct interactions within receptor-binding pockets contribute to receptor selectivity and activation.
Reference: Molecular Basis of Class B GPCR Selectivity for PACAP and VIP (2021).
Why Researchers Study VIP Receptor Signaling
VIP receptor research provides insight into several important areas of molecular biology and pharmacology.
These include:
- GPCR activation: Understanding how extracellular peptides trigger intracellular responses.
- Receptor selectivity: Identifying structural differences that influence ligand binding.
- Cell signaling: Investigating cAMP, PKA, EPAC, calcium, and related pathways.
- Neuroimmune communication: Studying interactions between neurological and immune signaling systems.
- Receptor regulation: Examining desensitization, internalization, and cellular responsiveness.
Many studies use isolated cells, recombinant receptor systems, animal models, or computational methods.
Their findings provide important mechanistic insights but do not necessarily predict outcomes in humans.
VIP Peptide for Laboratory Research
Research involving VIP often focuses on ligand-receptor interactions, receptor selectivity, and intracellular signaling pathways.
Researchers studying these mechanisms may require characterized peptide materials for controlled laboratory experiments.
Orion Peptides lists VIP (Vasoactive Intestinal Peptide) 5mg as a research-use-only compound.
When evaluating research materials, laboratories should assess peptide identity, batch documentation, analytical purity measurements, and the suitability of the material for their particular methods.
Researchers seeking a broader introduction to VIP’s molecular properties can also read What Is VIP Peptide? Structure, Function, and Research Overview.
Frequently Asked Questions
What is the mechanism of action of VIP peptide?
VIP primarily activates VPAC1 and VPAC2 receptors, stimulating Gαs-dependent adenylyl cyclase activity and increasing intracellular cAMP. This activates downstream signaling proteins, including PKA and EPAC, which regulate cell-specific responses.
What is the difference between VPAC1 and VPAC2?
VPAC1 and VPAC2 are distinct class B GPCRs encoded by VIPR1 and VIPR2, respectively. They share ligand-binding and signaling characteristics but differ in tissue distribution and regulatory properties.
Does VIP activate the PAC1 receptor?
VIP generally has substantially lower affinity for PAC1 than PACAP does. Its principal high-affinity receptors are VPAC1 and VPAC2.
Does VIP peptide increase cAMP?
Yes. Activation of VPAC1 or VPAC2 commonly stimulates adenylyl cyclase, increasing intracellular cAMP in responsive cells.
What is the relationship between VIP and PKA?
VIP receptor activation can elevate cAMP, which activates protein kinase A. PKA then phosphorylates proteins involved in various cellular signaling processes.
What is the role of VPAC2 in the brain?
VPAC2 participates in neuronal signaling, including the synchronization of neurons within the suprachiasmatic nucleus, which coordinates central circadian rhythms.
Conclusion
The VIP peptide mechanism of action is primarily mediated by VPAC1 and VPAC2 receptors, two class B G protein-coupled receptors that translate extracellular neuropeptide binding into intracellular signaling events.
The principal pathway involves Gαs activation, stimulation of adenylyl cyclase, increased cAMP production, and activation of PKA and other downstream proteins.
Additional pathways, including PLC and calcium signaling, may participate depending on the cellular environment.
Understanding these molecular mechanisms is essential for interpreting VIP research across neurological, gastrointestinal, immune, and vascular systems.
For a broader discussion of the peptide, explore What Is VIP Peptide? or review Orion Peptides’ VIP 5mg research compound.
Scientific References
- Harmar AJ, et al. (2012). Pharmacology and Functions of Receptors for Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide: IUPHAR Review 1. British Journal of Pharmacology.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3415633/ - Langer I. (2012). Mechanisms Involved in VPAC Receptors Activation and Regulation: Lessons From Pharmacological and Mutagenesis Studies. Frontiers in Endocrinology.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3483716/ - Couvineau A, Laburthe M. (2012). VPAC Receptors: Structure, Molecular Pharmacology and Interaction With Accessory Proteins. British Journal of Pharmacology.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3415636/ - Signal Transduction by VIP and PACAP Receptors (2022). Research review examining class B GPCR signaling and molecular mechanisms.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8962308/ - Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP (2021). Structural and computational analysis of receptor selectivity.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8027070/ - Vasoactive Intestinal Peptide: A Neuropeptide With Pleiotropic Immune Functions (2013). Review of immune-cell receptor signaling and immunomodulatory mechanisms.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3883350/ - Recent Advances in Vasoactive Intestinal Peptide Physiology and Pathophysiology: Focus on the Gastrointestinal System (2019).
https://pmc.ncbi.nlm.nih.gov/articles/PMC6743256/ - Targeting VIP and PACAP Receptor Signaling: New Insights Into Designing Drugs for the PACAP Subfamily of Receptors (2022). International Journal of Molecular Sciences.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9331257/
Research Disclaimer: This article is intended for scientific and educational purposes only. VIP research compounds are not intended for human or veterinary use. Findings from cellular, animal, and computational studies should not be interpreted as established clinical benefits or evidence of therapeutic safety.
